H19 and Parkinson disease: The study unveiled that the overexpression of H19 in the induced mice model of PD suppresses miR-301b-3p, resulting in the up-regulation of the Wnt/β-catenin pathway via HRPT modulation, thereby ameliorating the loss of dopamine neurons [98].